USA - NASDAQ:NRC - US6373722023 - Common Stock
Taking everything into account, NRC scores 4 out of 10 in our fundamental rating. NRC was compared to 101 industry peers in the Health Care Providers & Services industry. NRC scores excellent on profitability, but there are concerns on its financial health. NRC is valued expensive and it does not seem to be growing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.68% | ||
| ROE | 84.06% | ||
| ROIC | 20.28% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.88% | ||
| PM (TTM) | 12.78% | ||
| GM | 60.31% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.61 | ||
| Debt/FCF | 8.73 | ||
| Altman-Z | 2.73 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.7 | ||
| Quick Ratio | 0.7 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.14 | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29 | ||
| EV/EBITDA | 10.06 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.12% |
11.66
0 (0%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.12% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.14 | ||
| Fwd PE | N/A | ||
| P/S | 1.92 | ||
| P/FCF | 29 | ||
| P/OCF | 12.62 | ||
| P/B | 12.61 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.06 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.68% | ||
| ROE | 84.06% | ||
| ROCE | 26.45% | ||
| ROIC | 20.28% | ||
| ROICexc | 21.34% | ||
| ROICexgc | 67.64% | ||
| OM | 19.88% | ||
| PM (TTM) | 12.78% | ||
| GM | 60.31% | ||
| FCFM | 6.61% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.61 | ||
| Debt/FCF | 8.73 | ||
| Debt/EBITDA | 2.25 | ||
| Cap/Depr | 189.66% | ||
| Cap/Sales | 8.58% | ||
| Interest Coverage | 9.03 | ||
| Cash Conversion | 62.23% | ||
| Profit Quality | 51.72% | ||
| Current Ratio | 0.7 | ||
| Quick Ratio | 0.7 | ||
| Altman-Z | 2.73 |
ChartMill assigns a fundamental rating of 4 / 10 to NRC.
ChartMill assigns a valuation rating of 3 / 10 to NATIONAL RESEARCH CORP (NRC). This can be considered as Overvalued.
NATIONAL RESEARCH CORP (NRC) has a profitability rating of 8 / 10.
The financial health rating of NATIONAL RESEARCH CORP (NRC) is 3 / 10.
The dividend rating of NATIONAL RESEARCH CORP (NRC) is 5 / 10 and the dividend payout ratio is 62.38%.